Basic Information
| LncRNA/CircRNA Name | SUMO1P3 |
| Synonyms | NA |
| Region | GRCh38_1:160317403-160317706 |
| Ensemble | ENSG00000235082 |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | colon cancer |
| ICD-0-3 | C18 |
| Methods | qPCR, Western blot |
| Sample | colon cancer tissues, cell lines (HT29, HCT116, SW480, SW620, and LoVo, NCM460 and HUVECs) |
| Expression Pattern | up-regulated |
| Function Description | The upregulation of SUMO1P3 was positively correlated with the advanced histological stages, metastases, angiogenesis and poor prognosis of colon cancer patients. SUMO1P3 knockdown repressed the proliferation, migration,invasion, and pro-angiogenesis of colon cancer cells in vitro. SUMO1P3 silencing reduced the growth, liver metastasis, and vascularization of colon cancer in vivo. SUMO1P3 depletion decreased the levels of cyclin D1, Vimentin, and VEGFA while increased E-cadherin expression in xenograft tumor tissues.the patients with high levels of SUMO1P3 had shorter survival rates than those with low levels of SUMO1P3. |
| Pubmed ID | 29312498 |
| Year | 2017 |
| Title | LncRNA SUMO1P3 drives colon cancer growth, metastasis and angiogenesis. |
External Links
| Links for SUMO1P3 | GenBank HGNC NONCODE |
| Links for colon cancer | OMIM COSMIC |